Bruker Corporation (BRKR)
BRKR Stock Price Chart
Explore Bruker Corporation interactive price chart. Choose custom timeframes to analyze BRKR price movements and trends.
BRKR Company Profile
Discover essential business fundamentals and corporate details for Bruker Corporation (BRKR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
4 Aug 2000
Employees
11.40k
Website
https://www.bruker.comCEO
Frank H. Laukien
Description
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
BRKR Financial Timeline
Browse a chronological timeline of Bruker Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is $0.38, while revenue estimate is $853.57m.
Dividend declared on 22 Jun 2026
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 7 Jul 2026.
Earnings released on 6 May 2026
EPS came in at $0.31 surpassing the estimated $0.23 by +34.78%, while revenue for the quarter reached $823.40m , beating expectations by +3.49%.
Dividend declared on 23 Mar 2026
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 7 Apr 2026.
Earnings released on 12 Feb 2026
EPS came in at $0.59 falling short of the estimated $0.65 by -9.23%, while revenue for the quarter reached $977.20m , beating expectations by +1.55%.
Dividend declared on 8 Dec 2025
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 2 Jan 2026.
Earnings released on 3 Nov 2025
EPS came in at $0.60 surpassing the estimated $0.33 by +81.82%, while revenue for the quarter reached $860.50m , missing expectations by -10.79%.
Dividend declared on 23 Sept 2025
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 3 Oct 2025.
Earnings released on 4 Aug 2025
EPS came in at $0.32 falling short of the estimated $0.33 by -3.03%, while revenue for the quarter reached $797.40m , missing expectations by -1.57%.
Dividend declared on 16 Jun 2025
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 27 Jun 2025.
Earnings released on 7 May 2025
EPS came in at $0.47 surpassing the estimated $0.46 by +2.17%, while revenue for the quarter reached $801.40m , missing expectations by -2.26%.
Dividend declared on 17 Mar 2025
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 28 Mar 2025.
Earnings released on 13 Feb 2025
EPS came in at $0.76 surpassing the estimated $0.75 by +1.33%, while revenue for the quarter reached $979.60m , beating expectations by +1.45%.
Dividend declared on 2 Dec 2024
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 16 Dec 2024.
Earnings released on 5 Nov 2024
EPS came in at $0.60 falling short of the estimated $0.61 by -1.64%, while revenue for the quarter reached $864.40m , beating expectations by +0.58%.
Dividend declared on 30 Aug 2024
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 16 Sept 2024.
Earnings released on 6 Aug 2024
EPS came in at $0.52 matching the estimated $0.52, while revenue for the quarter reached $800.70m , beating expectations by +0.52%.
Dividend declared on 3 Jun 2024
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 17 Jun 2024.
Earnings released on 2 May 2024
EPS came in at $0.53 surpassing the estimated $0.46 by +15.22%, while revenue for the quarter reached $721.70m , missing expectations by -1.12%.
Dividend declared on 29 Feb 2024
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 15 Mar 2024.
Earnings released on 13 Feb 2024
EPS came in at $0.70 surpassing the estimated $0.65 by +7.69%, while revenue for the quarter reached $854.50m , beating expectations by +5.82%.
Dividend declared on 30 Nov 2023
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 15 Dec 2023.
Earnings released on 2 Nov 2023
EPS came in at $0.74 surpassing the estimated $0.63 by +17.46%, while revenue for the quarter reached $742.80m , beating expectations by +3.77%.
Dividend declared on 31 Aug 2023
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 15 Sept 2023.
Earnings released on 3 Aug 2023
EPS came in at $0.50 surpassing the estimated $0.49 by +2.04%, while revenue for the quarter reached $681.90m , beating expectations by +5.25%.
Dividend declared on 31 May 2023
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 16 Jun 2023.
Earnings released on 4 May 2023
EPS came in at $0.64 surpassing the estimated $0.55 by +16.36%, while revenue for the quarter reached $685.30m , beating expectations by +7.12%.
Dividend declared on 28 Feb 2023
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 17 Mar 2023.
Earnings released on 9 Feb 2023
EPS came in at $0.74 surpassing the estimated $0.72 by +2.78%, while revenue for the quarter reached $708.40m , beating expectations by +4.16%.
Dividend declared on 30 Nov 2022
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 16 Dec 2022.
Earnings released on 3 Nov 2022
EPS came in at $0.66 surpassing the estimated $0.55 by +20.00%, while revenue for the quarter reached $638.90m , beating expectations by +4.74%.
Dividend declared on 31 Aug 2022
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 16 Sept 2022.
Earnings released on 3 Aug 2022
EPS came in at $0.45 matching the estimated $0.45, while revenue for the quarter reached $588.40m , beating expectations by +0.03%.
Dividend declared on 31 May 2022
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 17 Jun 2022.
Earnings released on 4 May 2022
EPS came in at $0.49 surpassing the estimated $0.42 by +16.67%, while revenue for the quarter reached $595.00m , beating expectations by +3.92%.
Dividend declared on 28 Feb 2022
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 18 Mar 2022.
Earnings released on 11 Feb 2022
EPS came in at $0.59 surpassing the estimated $0.58 by +1.72%, while revenue for the quarter reached $683.50m , beating expectations by +3.26%.
Dividend declared on 30 Nov 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 17 Dec 2021.
Earnings released on 1 Nov 2021
EPS came in at $0.63 surpassing the estimated $0.44 by +43.18%, while revenue for the quarter reached $608.90m , beating expectations by +5.83%.
Dividend declared on 31 Aug 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 17 Sept 2021.
Earnings released on 2 Aug 2021
EPS came in at $0.44 surpassing the estimated $0.38 by +15.79%, while revenue for the quarter reached $570.80m , beating expectations by +5.96%.
BRKR Stock Performance
Access detailed BRKR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
